Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 31, 2023

SELL
$132.51 - $164.9 $47,306 - $58,869
-357 Reduced 18.88%
1,534 $206,000
Q4 2021

Jan 31, 2022

BUY
$107.43 - $135.93 $203,150 - $257,043
1,891 New
1,891 $256,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $337B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Del Sette Capital Management, LLC Portfolio

Follow Del Sette Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Del Sette Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Del Sette Capital Management, LLC with notifications on news.